Stocks · Korea
348150
KOSDAQ
KoBioLabs
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+3.60%
1M+1.41%
3M-14.56%
6M-51.68%
1Y-53.10%
YTD-50.77%
52W high8,730원
52W low2,310원
From 52W high-67.07%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 116억 | -203억 | -234억 | -174.8% |
| 2023 | 331억 | -185억 | -152억 | -55.7% |
| 2024 | 684억 | -69억 | -46억 | -10.1% |
| 2025 | 693억 | -97억 | -70억 | -13.9% |
| Quarterly | ||||
| 2024 4Q | 176억 | -17억 | -11억 | -9.4% |
| 2025 1Q | 173억 | -35억 | -31억 | -20.0% |
| 2025 2Q | 176억 | -28억 | -32억 | -15.9% |
| 2025 3Q | 193억 | -4억 | 9억 | -2.2% |
| 2025 4Q | 151억 | -30억 | -16억 | -19.6% |
| 2026 1Q | 192억 | -27억 | -2억 | -13.9% |
Company
Address: 서울특별시 관악구 관악로 1 220동 745-1호(신림동, 서울대학교종합연구동)
Peers in the same sector
Recent filings
- 2026-08-13반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-06-18'실패한 줄 알았던 치료제의 반전'…고바이오랩, 건선 핵심 스위치 찾.... 이데일리
- 2026-06-16고바이오랩, BIO USA 2026 참가…글로벌 협력 기회 모색 이데일리
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.